Institutional Biosafety Committee

Increasingly, leading-edge, first-in-man therapeutic research is being performed in Australia making use of the high-tech facilities and world class expertise. It was for this reason, that Australia’s first independent Institutional Biosafety Committee (IBC) was established by Queensland Clinical Trials Network (QCTN), now known as, Life Sciences Queensland Limited in 2006. Organisations who are accredited to deal with genetically modified organisms (GMOs) must have access to an IBC, must approve a GMO licence prior to submitting to the Office of Gene Technology Regulator (OGTR).